Flexcin International, the makers of Flexcin with CM8™ joint supplement for people, and FlexPet with CM8® joint supplement for dogs, reports sales increases from Canada in conjunction with a new study that says 1 in 5 Canadians may suffer from arthritis by 2031.

The Public Health Agency of Canada recently issued a new report saying 1 in 5 Canadians may suffer from arthritis by the year 2031. The report also states that in 2008 there were 4.2 million Canadians (roughly 16% of population of at least 15 years old) who were already suffering from arthritis.

Through June, 2010, certain regions of Canada are growing faster for Flexcin sales compared with many areas of the United States. Regions such as Toronto, Montreal, Calgary, Vancouver and Quebec have become five of the top 20 fastest-growing markets in all of North America for Flexcin. Just three years ago only Toronto was in the top-20 list for Flexcin growth in North America. Canada also ranks as the number-one country outside of the U.S. for all Flexcin product demand.

“This regional growth in parts of Canada shows the high level of interest Canadians now have in supplements as a way to stay healthy without relying on prescribed medicines,” said Tamer Elsafy, CEO and founder of Flexcin. “Natural supplements are becoming a popular choice among people dealing with all sorts of pain who have grown frustrated with existing treatment options.”

Flexcin is a natural supplement that supports healthy joint mobility by increasing the growth of cartilage throughout the body. These five Canadian cities now rank higher in Flexcin volume than U.S. cities previously listed in the top-20, including St. Louis, Cincinnati, Kansas City, Hartford, and Pittsburgh.

Do you live in Canada and take a natural supplement for your joint inflammation? Tell us about it here.